Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Pentoxifylline as Add-On Therapy for Mild-to-Moderate Plaque Psoriasis: A Double-Blind Randomized Placebo-Controlled Trial

NCT07626788 is registered in ClinicalTrials.gov with Wasuchon Chaichan as lead sponsor.

NCT NCT07626788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07626788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Pentoxifylline as Add-On Therapy for Mild-to-Moderate Plaque Psoriasis: A Double-Blind Randomized Placebo-Controlled Trial
Lead sponsor
Wasuchon Chaichan
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
October 31, 2028
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis